Note in the announcement below it states the second option agreement was expanding the existing agreement and was an extension. Therefore should we not be looking at 17th Nov being the expiry of the Japanese option agreements and not Oct 29th which was the expiry prior to this second deal. I am sure the Japanese would see it that way.
17 May 2016, Melbourne: Australian biotechnology company, Phosphagenics Limited (ASX: POH; OTCQX: PPGNY), today announced that it has expanded its existing license option agreement, with one of Japan’s largest healthcare companies, to include its TPM®/Oxycodone patch. This agreement is an extension to the agreement announced on 29th April 2016 for a license option to the TPM®/Oxymorphone patch and an R&D alliance for three other TPM® based products.
The Japanese healthcare company, not to be disclosed at present, has now entered into an agreement for an exclusive 6-month option to obtain an exclusive license to Phosphagenics’ TPM®/Oxycodone patch in Japan
Note in the announcement below it states the second option...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.508M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $230 | 76.53K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 50 | 94525533 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 21246560 | 13 |
View Market Depth
| Last trade - 15.57pm 24/06/2024 (20 minute delay) ? |
| AVE (ASX) Chart |